{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:26:48Z","timestamp":1792175208551,"version":"4.4.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131427","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:23:39Z","timestamp":1712355819000},"page":"131427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"P1","title":["Review: N1-methyl-pseudouridine (m1\u03a8): Friend or foe of cancer?"],"prefix":"10.1016","volume":"267","author":[{"given":"Alberto","family":"Rubio-Casillas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikolaj","family":"Raszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elrashdy M.","family":"Redwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.131427_bb0005","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3389\/fcell.2021.789427","article-title":"The critical contribution of pseudouridine to mRNA COVID-19 vaccines","volume":"9","author":"Morais","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131427_bb0010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14712598.4.8.1285","article-title":"Messenger RNA-based vaccines","volume":"4","author":"Pascolo","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.131427_bb0015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3302964","article-title":"Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent","volume":"14","author":"Probst","year":"2007","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","article-title":"The promise of mRNA vaccines: a biotech and industrial perspective","volume":"5","author":"Jackson","year":"2020","journal-title":"npj Vaccines"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/v13020270","article-title":"Synthetic messenger RNA-based vaccines: from scorn to hype","volume":"13","author":"Pascolo","year":"2021","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.131427_bb0030","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1093\/nar\/12.18.7057","article-title":"Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs","volume":"12","author":"Krieg","year":"1984","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.131427_bb0035","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1093\/nar\/12.18.7035","article-title":"Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter","volume":"12","author":"Melton","year":"1984","journal-title":"Nucleic Acids Res."},{"issue":"4949","key":"10.1016\/j.ijbiomac.2024.131427_bb0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131427_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"5674","key":"10.1016\/j.ijbiomac.2024.131427_bb0055","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/274923a0","article-title":"Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes","volume":"274","author":"Dimitriadis","year":"1978","journal-title":"Nature"},{"issue":"5674","key":"10.1016\/j.ijbiomac.2024.131427_bb0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/274921a0","article-title":"Evidence for translation of rabbit globin mRNA after liposomemediated insertion into a human cell line","volume":"274","author":"Ostro","year":"1978","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.131427_bb0065","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131427_bb0070","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/eji.1830230749","article-title":"Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA","volume":"23","author":"Martinon","year":"1993","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0075","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0090","series-title":"Cold Spring Harbor Symposia on Quantitative Biology","article-title":"Approaching the asymptote? Evolution and revolution in immunology","author":"Janeway","year":"1989"},{"issue":"5963","key":"10.1016\/j.ijbiomac.2024.131427_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"Iwasaki","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131427_bb0100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/annonc\/mdx179","article-title":"Pattern recognition receptors: immune targets to enhance cancer immunotherapy","volume":"28","author":"Shekarian","year":"2017","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2013.07.011","article-title":"Turning tumors into vaccines: co-opting the innate immune system","volume":"39","author":"van den Boorn","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0120","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1073\/pnas.1019059108","article-title":"RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation","volume":"108","author":"Jiang","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131427_bb0125","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8\u03b1+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","article-title":"Type I interferon response and innate immune sensing of cancer","volume":"34","author":"Fuertes","year":"2013","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131427_bb0135","first-page":"2399","article-title":"Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon\u2013independent apoptosis in human melanoma cells","volume":"119","author":"Besch","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2013.05.007","article-title":"Cytosolic sensing of viruses","volume":"38","author":"Goubau","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s43856-022-00083-x","article-title":"BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant","volume":"2","author":"Knabl","year":"2022","journal-title":"Commun. Med."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.131427_bb0150","doi-asserted-by":"crossref","first-page":"12332","DOI":"10.1128\/JVI.01325-06","article-title":"RNA-and virus-independent inhibition of antiviral signaling by RNA helicase LGP2","volume":"80","author":"Komuro","year":"2006","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.131427_bb0155","doi-asserted-by":"crossref","first-page":"10733","DOI":"10.1128\/JVI.00510-12","article-title":"LGP2 downregulates interferon production during infection with seasonal human influenza A viruses that activate interferon regulatory factor 3","volume":"86","author":"Malur","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131427_bb0160","doi-asserted-by":"crossref","first-page":"E484","DOI":"10.1073\/pnas.1323253111","article-title":"RIG-I\u2013like receptor LGP2 protects tumor cells from ionizing radiation","volume":"111","author":"Widau","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00833-16","article-title":"RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling","volume":"7","author":"Durbin","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113008","article-title":"Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs","volume":"164","author":"Seneff","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.983000","article-title":"mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model","volume":"13","author":"Sittplangkoon","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0180","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","article-title":"Modifications in an emergency: the role of N1-methylpseudouridine in COVID-19 vaccines","volume":"7","author":"Nance","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"27","key":"10.1016\/j.ijbiomac.2024.131427_bb0185","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131427_bb0190","first-page":"728","article-title":"Pfizer\u2019s COVID-19 vaccine secures first full FDA approval","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7003","key":"10.1016\/j.ijbiomac.2024.131427_bb0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","article-title":"Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries","volume":"311","author":"Aaby","year":"1995","journal-title":"Bmj"},{"issue":"7274","key":"10.1016\/j.ijbiomac.2024.131427_bb0200","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","article-title":"Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa commentary: an unexpected finding that needs confirmation or rejection","volume":"321","author":"Kristensen","year":"2000","journal-title":"Bmj"},{"issue":"43","key":"10.1016\/j.ijbiomac.2024.131427_bb0205","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131427_bb0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab\u2013a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131427_bb0220","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cmi.2019.08.011","article-title":"Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies","volume":"25","author":"Aaby","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0225","series-title":"Do vaccines increase or decrease susceptibility to diseases other than those they protect against?","author":"Rubio-Casillas","year":"2023"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131427_bb0230","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design","volume":"198","author":"Pepini","year":"2017","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131427_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108572","article-title":"mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection","volume":"26","author":"Ivanova","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-021-00329-3","article-title":"Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discovery"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109762","article-title":"The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses","volume":"255","author":"F\u00f6hse","year":"2023","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0250","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2012.202","article-title":"Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines","volume":"21","author":"Pollard","year":"2013","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0255","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.4049\/jimmunol.0900080","article-title":"PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo","volume":"182","author":"Chikuma","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6145-8","article-title":"IFN-\u03b3 down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.131427_bb0265","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1158\/0008-5472.CAN-16-3167","article-title":"PD-1 status in CD8+ T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer","volume":"77","author":"Kansy","year":"2017","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131427_bb0270","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/bjc.2014.416","article-title":"PD-1+ CD8+ T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131427_bb0275","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.0803245","article-title":"PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients","volume":"182","author":"Fourcade","year":"2009","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.131427_bb0280","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/pros.21020","article-title":"Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+","volume":"69","author":"Sfanos","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00262-014-1519-x","article-title":"PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients","volume":"63","author":"Sun","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.582863","article-title":"Estrogen receptor downregulates expression of PD-1\/PD-L1 and infiltration of CD8+ T cells by inhibiting IL-17 signaling transduction in breast cancer","volume":"10","author":"Shuai","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131427_bb0295","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/s41416-022-01939-8","article-title":"Intratumoral PD-1+ CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer","volume":"127","author":"Yu","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0300","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.2147\/CMAR.S172039","article-title":"Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors","author":"Yao","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2020.10.028","article-title":"Dynamic changes in circulating PD-1+ CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer","volume":"143","author":"Kim","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0310","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/0008-5472.CAN-22-3864","article-title":"Terminally exhausted CD8+ T cells resistant to PD-1 blockade promote generation and maintenance of aggressive cancer stem cells","volume":"83","author":"Chakravarti","year":"2023","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0315","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1074-7613(03)00178-X","article-title":"Monocyte heterogeneity and innate immunity","volume":"19","author":"Taylor","year":"2003","journal-title":"Immunity"},{"issue":"6035","key":"10.1016\/j.ijbiomac.2024.131427_bb0325","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1204351","article-title":"Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation","volume":"332","author":"Jenkins","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0330","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","article-title":"Distinct role of macrophages in different tumor microenvironments","volume":"66","author":"Lewis","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0335","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/eji.201141670","article-title":"Regulators of macrophage activation","volume":"41","author":"Martinez","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0340","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0345","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0350","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ajpath.2013.06.034","article-title":"Phenotypic transitions of macrophages orchestrate tissue repair","volume":"183","author":"Novak","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0355","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.4049\/jimmunol.0803567","article-title":"Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity","volume":"183","author":"Schreiber","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/mt.2011.189","article-title":"Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation","volume":"20","author":"Fran\u00e7ois","year":"2012","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0365","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"issue":"7519","key":"10.1016\/j.ijbiomac.2024.131427_bb0370","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131427_bb0375","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ijc.23527","article-title":"Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival","volume":"123","author":"Shabo","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0380","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09031936.00065708","article-title":"Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival","volume":"33","author":"Ohri","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0385","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.intimp.2017.05.014","article-title":"Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis","volume":"49","author":"Yuan","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0390","first-page":"301","article-title":"IFN-\u03b1 facilitates the effect of sorafenib via shifting the M2-like polarization of TAM in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-1163-9","article-title":"M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int. Immunol."},{"issue":"7007","key":"10.1016\/j.ijbiomac.2024.131427_bb0405","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","article-title":"An inflammatory link","volume":"431","author":"Balkwill","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0410","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","article-title":"TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance","volume":"44","author":"He","year":"2007","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0415","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1053\/j.gastro.2007.09.008","article-title":"Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors","volume":"133","author":"Fukata","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131427_bb0420","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.anndiagpath.2015.04.008","article-title":"Toll-like receptor 4\u2013induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma","volume":"19","author":"Wang","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0425","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4161\/rna.20206","article-title":"RNA mediated Toll-like receptor stimulation in health and disease","volume":"9","author":"Dalpke","year":"2012","journal-title":"RNA Biol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.131427_bb0430","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.M412584200","article-title":"The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling","volume":"280","author":"Schoenemeyer","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0435","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imbio.2017.10.005","article-title":"The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2","volume":"223","author":"Chistiakov","year":"2018","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0445","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00011-013-0645-9","article-title":"Immune system: a double-edged sword in cancer","volume":"62","author":"Lakshmi Narendra","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0450","first-page":"1","article-title":"N 1-methylpseudouridylation of mRNA causes+ 1 ribosomal frameshifting","author":"Mulroney","year":"2023","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.131427_bb0455","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.molcel.2021.09.002","article-title":"Oncogene-dependent sloppiness in mRNA translation","volume":"81","author":"Champagne","year":"2021","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0460","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.tig.2022.05.009","article-title":"Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting","volume":"38","author":"Champagne","year":"2022","journal-title":"Trends in Genetics"},{"issue":"7845","key":"10.1016\/j.ijbiomac.2024.131427_bb0465","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","article-title":"Anti-tumour immunity induces aberrant peptide presentation in melanoma","volume":"590","author":"Bartok","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131427_bb0470","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/biomedicines10071538","article-title":"Vaccine mRNA can be detected in blood at 15 days post-vaccination","volume":"10","author":"Fertig","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131427_bb0475","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0480","author":"Public Assessment Report for COVID-19 Vaccine Pfizer\/BioNTech"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0485","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s43055-022-00896-9","article-title":"Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation","volume":"54","author":"El Sammak","year":"2023","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131427_bb0490","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230743","article-title":"Assessment of myocardial 18F-FDG uptake at PET\/CT in asymptomatic SARS-CoV-2\u2013vaccinated and nonvaccinated patients","volume":"308","author":"Nakahara","year":"2023","journal-title":"Radiology"},{"issue":"7870","key":"10.1016\/j.ijbiomac.2024.131427_bb0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"issue":"6\u20137","key":"10.1016\/j.ijbiomac.2024.131427_bb0500","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbagrm.2013.03.005","article-title":"XRN 5\u2032\u2192 3\u2032 exoribonucleases: structure, mechanisms and functions","volume":"1829","author":"Nagarajan","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.39","article-title":"Cap 1 messenger RNA synthesis with co-transcriptional Cleancap\u00ae analog by in vitro transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Current Protocols"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0510","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202300048","article-title":"Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS\u2010CoV\u20102: Possible molecular mechanisms","volume":"17","author":"Brogna","year":"2023","journal-title":"PROTEOMICS\u2013Clinical Applications"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110114","article-title":"Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern","volume":"37","author":"Farkash","year":"2021","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131427_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104766","article-title":"Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants","volume":"25","author":"Emmenegger","year":"2022","journal-title":"Iscience"},{"issue":"79","key":"10.1016\/j.ijbiomac.2024.131427_bb0525","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2022","journal-title":"Science Immunology"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0530","first-page":"13","article-title":"mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine","author":"Buhre","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0535","article-title":"Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after mRNA but not adenovirus priming","author":"Hartley","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40103-x","article-title":"Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history","volume":"13","author":"Kiszel","year":"2023","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.131427_bb0545","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172470","article-title":"Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections","volume":"8","author":"Selva","year":"2023","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131427_bb0550","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3390\/vaccines11111720","article-title":"Dynamics of serum-neutralizing antibody responses in vaccinees through multiple doses of the BNT162b2 vaccine","volume":"11","author":"Sheehan","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0555","article-title":"Suppressed IgG4 class switching in dupilumab-and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination","author":"Valk","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0560","series-title":"International Journal of Infectious Diseases","first-page":"1","article-title":"The appearance of anti-spike receptor binding domain immunoglobulin G4 responses after repetitive immunization with messenger RNA-based COVID-19 vaccines","volume":"139","author":"Yoshimura","year":"2024"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1309997","article-title":"Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations","volume":"14","author":"Akhtar","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0570","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/v16020187","article-title":"The anti-SARS-CoV-2 IgG1 and IgG3 antibody isotypes with limited neutralizing capacity against omicron elicited in a Latin population a switch toward IgG4 after multiple doses with the mRNA Pfizer\u2013BioNTech vaccine","volume":"16","author":"Espino","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0575","article-title":"Altered IgG4 antibody response to repeated mRNA versus protein COVID vaccines","author":"Kalkeri","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0580","article-title":"Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19","volume":"15","author":"Adhikari","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0585","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/vaccines11050991","article-title":"IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein","volume":"11","author":"Uversky","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131427_bb0590","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/jacs.9b11050","article-title":"Interplay of guanine oxidation and G-quadruplex folding in gene promoters","volume":"142","author":"Fleming","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.131427_bb0595","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1093\/nar\/gkaa944","article-title":"G-quadruplex\u2013R-loop interactions and the mechanism of anticancer G-quadruplex binders","volume":"48","author":"Miglietta","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131427_bb0600","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0021-9258(17)49903-0","article-title":"The balancing act of R-loop biology: the good, the bad, and the ugly","volume":"295","author":"Hegazy","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.ijbiomac.2024.131427_bb0605","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1016\/j.vaccine.2023.07.007","article-title":"COVID-19 mRNA vaccines as hypothetical epigenetic players: results from an in silico analysis, considerations and perspectives","volume":"41","author":"Talotta","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131427_bb0610","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1261\/rna.053918.115","article-title":"The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2","volume":"21","author":"Davidovich","year":"2015","journal-title":"Rna"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0615","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygeno.2014.11.007","article-title":"AEBP2 as a transcriptional activator and its role in cell migration","volume":"105","author":"Kim","year":"2015","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198945","article-title":"Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer","volume":"13","author":"Eastlack","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0625","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/odi.12825","article-title":"Sj\u00f6gren\u2019s syndrome X-chromosome dose effect: an epigenetic perspective","volume":"25","author":"Mougeot","year":"2019","journal-title":"Oral Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0630","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/08971900211009650","article-title":"Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273","volume":"35","author":"Teo","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0635","series-title":"Moderna's COVID-19 vaccine Candidate Meets Its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study","author":"Moderna","year":"2020"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0640","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0645","doi-asserted-by":"crossref","DOI":"10.15190\/d.2021.1","article-title":"First COVID-19 vaccines receiving the US FDA and EMA emergency use authorization","volume":"9","author":"Fortner","year":"2021","journal-title":"Discoveries"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0650","series-title":"Holland-Frei Cancer Medicine 8","volume":"8","author":"Holland","year":"2010"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131427_bb0655","first-page":"117","article-title":"SARS-CoV-2 infection: a possible risk factor for incidence and recurrence of cancers","volume":"16","author":"Jafarzadeh","year":"2022","journal-title":"International Journal of Hematology-Oncology and Stem Cell Research"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1260776","article-title":"SARS-CoV-2 infection as a potential risk factor for the development of cancer","volume":"10","author":"Ogarek","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"26","key":"10.1016\/j.ijbiomac.2024.131427_bb0665","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.2217\/fon-2021-0121","article-title":"Cancer and COVID-19: analysis of patient outcomes","volume":"17","author":"Aboueshia","year":"2021","journal-title":"Future Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131427_bb0670","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/bjd.20630","article-title":"Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination","volume":"185","author":"Gambichler","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.131427_bb0675","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.3390\/cancers14174330","article-title":"COVID-19 vs. cancer immunosurveillance: a game of thrones within an inflamed microenviroment","volume":"14","author":"Liapis","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-04110-w","article-title":"Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment","volume":"21","author":"Meo","year":"2023","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131427_bb0685","article-title":"SARS-CoV-2 vaccination and the multi-hit hypothesis of oncogenesis","volume":"15","author":"Valdes Angues","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0690","article-title":"B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB\/c mouse: a case report","volume":"13","author":"Eens","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0695","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0047-6374(00)00256-6","article-title":"Long-live euthymic BALB\/c-nu mice. I. Survival study suggests body weight as a life span predictor","volume":"122","author":"Piantanelli","year":"2001","journal-title":"Mech. Ageing Dev."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131427_bb0700","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1080\/10428194.2021.1924371","article-title":"Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination","volume":"62","author":"Brumfiel","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0705","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3389\/fmed.2021.798095","article-title":"Rapid progression of angioimmunoblastic T cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report","volume":"8","author":"Goldman","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0710","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdcr.2022.08.006","article-title":"Subcutaneous panniculitis-like T-cell lymphoma after COVID-19 vaccination","volume":"28","author":"Kreher","year":"2022","journal-title":"JAAD Case Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131427_bb0715","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/medicina58070874","article-title":"Hematologic malignancies diagnosed in the context of the mRNA COVID-19 vaccination campaign: a report of two cases","volume":"58","author":"Zamfir","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0720","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/medicina59010157","article-title":"Non-Hodgkin lymphoma developed shortly after mRNA COVID-19 vaccination: report of a case and review of the literature","volume":"59","author":"Cavanna","year":"2023","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131427_bb0725","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/jdv.18615","article-title":"Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site","volume":"37","author":"Revenga-Porcel","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0730","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/746769","article-title":"Estimating cancer latency times using a Weibull model","volume":"2014","author":"Nadler","year":"2014","journal-title":"Advances in Epidemiology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131427_bb0735","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14136","article-title":"Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria","volume":"54","author":"Chalupka","year":"2024","journal-title":"Eur. J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0740","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28786","article-title":"COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: differences between vaccine subtypes. A multicontinental cohort study","volume":"95","author":"Huespe","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2024.131427_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.873596","article-title":"The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis","volume":"10","author":"Rahmani","year":"2022","journal-title":"Front. Public Health"},{"issue":"31","key":"10.1016\/j.ijbiomac.2024.131427_bb0750","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1016\/j.vaccine.2023.06.005","article-title":"Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021-January 2022","volume":"41","author":"de Gier","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131427_bb0755","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s11606-022-08007-0","article-title":"The relationship of COVID-19 vaccination with mortality among 86,732 hospitalized patients: subpopulations, patient factors, and changes over time","volume":"38","author":"Baker","year":"2023","journal-title":"J. Gen. Intern. Med."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2024.132447","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024022323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024022323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T11:10:54Z","timestamp":1718536254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024022323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":151,"alternative-id":["S0141813024022323"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131427","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijbiomac.2024.132447","asserted-by":"object"}]},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: N1-methyl-pseudouridine (m1\u03a8): Friend or foe of cancer?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131427"}}